Clinical Trials Search Results

  • Resize font
  • Print
  • Email
  • Facebook
  • Twitter
  • Google+
  • Pinterest
Drug:  F-18 16 alpha-fluoroestradiol
Find trials that include:  Any drugs shown
Results 1-3 of 3 for your search:
Start Over
FES PET/CT in Predicting Response in Patients with Newly Diagnosed Metastatic Breast Cancer Receiving Endocrine Therapy
Phase: Phase II
Type: Diagnostic
Age: 19 and over
Trial IDs: EAI142, NCI-2015-00383, PEAI142_R01PAPP01, NCT02398773
F-18 FES PET in Measuring Hormone Expression in Patients with Primary, Recurrent or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy
Phase: No phase specified
Type: Biomarker/Laboratory analysis, Diagnostic
Age: 18 and over
Trial IDs: 7184, NCI-2013-02342, NCT02149173
FES-PET/CT in Predicting Treatment Response in Patients with Endocrine Refractory, Recurrent or Metastatic Estrogen Receptor-Positive Breast Cancer
Phase: No phase specified
Type: Diagnostic
Age: 18 and over
Trial IDs: UPCC 20114, NCI-2015-01008, 821717, NCT02409316
Start Over